| ||Audit Committee ||Compensation Committee||Nominating and Corporate Governance Committee||Compliance Committee|
|Robert E. Curry, Ph.D. |
|Robert E. Curry, Ph.D.|
Robert E. Curry, Ph.D. has served on our board of directors since February 2002. Since July 2002, Dr. Curry has served as a venture partner at Alliance Technology Ventures, L.P., based in Atlanta, Georgia. From July 2001 to July 2002, Dr. Curry was engaged as a consultant to DLJ Capital Corporation, a wholly-owned subsidiary of Credit Suisse First Boston (USA), Inc., or CSFB. He joined the Sprout Group, or Sprout, a submanager of various venture capital funds within the CSFB organization,...
|| || ||
|Karin Eastham |
Karin Eastham joined our board in 2008. She served as the Executive Vice President, Chief Operating Officer, and Trustee for the Burnham Institute for Medical Research from 2004 until 2008. Prior to this, Ms. Eastham was the Senior Vice President of Finance and the Chief Financial Officer for Diversa Corporation. She has also served in similar senior level management roles at Combichem, Inc., Cytel Corporation and Boehringer Mannheim Diagnostics. She currently serves on the Boards of Directo...
|Michael Henos |
Michael A. Henos has served on our board of directors since 2001. From 1993 to the present, Mr. Henos has served as managing general partner of Alliance Technology Ventures, L.P., based in Atlanta, Georgia. Mr. Henos served as a general partner of Aspen Ventures, an early stage venture capital partnership, from 1991 to 2001. Mr. Henos previously served as a vice president of 3i Ventures Corporation, the predecessor of Aspen Ventures, from 1986 to 1991. From 1984 to 1986, Mr. Henos served ...
|| || |
|Laurence R. McCarthy, Ph.D. |
|Laurence R. McCarthy, Ph.D.|
Laurence R. McCarthy, Ph.D., joined our board in 2008. He is a Venture Partner with Ampersand Ventures and President of Scientific Technologies and Solutions, LLC. Dr. McCarthy was President, CEO, Chairman and CTO of Focus Diagnostics and later served as its CTO following the company’s acquisition by Quest Diagnostics. Prior to this, he was President for the U.S. Diagnostics Division of Boehringer Mannheim; Vice President and General Manager and Vice President R&D for Becton Dickinson & Co. ...
| || || ||
|Geoffrey M. Parker |
|Geoffrey M. Parker|
Geoffrey M. Parker joined our board of directors in June 2010. Mr. Parker is currently the Senior Vice President and Chief Financial Officer for Anacor Pharmaceuticals, a biopharmaceutical company developing novel small-molecule therapeutics, were he has served in a consulting capacity since December of 2009. From July 2009 to July 2010, Mr. Parker acted as an advisor in his role as the Chief Business Officer of InteKrin Therapeutics, a privately held biopharmaceutical company in Los ...
|Drew Senyei, M.D. |
|Drew Senyei, M.D.|
Andrew E. Senyei, M.D. has served on our board of directors as chairman of the board since April 2000. Dr. Senyei has been a managing director and a general partner of Enterprise Partners, a venture capital firm, since 1987. Dr. Senyei was a founder of Molecular Biosystems and, prior to joining Enterprise Partners, was a practicing clinician and adjunct associate professor of obstetrics, gynecology and pediatrics at the University of California, Irvine. He serves on the boards of director...
|Christine A. White, M.D. |
|Christine A. White, M.D.|
Christine A. White, M.D., became a member of the Board of Directors in January 2009. Dr. White was with Biogen Idec Inc., a biopharmaceutical company, from 1996 to 2005, where she held several senior positions, most recently as Senior Vice President, Global Medical Affairs. From 1994 to 1996, Dr. White served as the Director of Clinical Oncology Research at the Sidney Kimmel Cancer Center in San Diego and from 1984 to 1994, Dr. White was on the clinical staff and held various positions in the De...